Kennedy Trust for Rheumatology Research v Hospira Healthcare Corporation
2018
A-360-18
Resolved
Biosimilars
Interlocutory appeal in a patent impeachment action regarding Patent No. 2,261,630 (infliximab)
Counsel to:
Hospira Healthcare Corporation, Celltrion Healthcare Co. Ltd., Celltrion Inc. and Pfizer Canada Inc.
The decision is reported
here.
Meet the team

Warren Sprigings
Partner